Clever Leaves Holdings Inc. (CLVR)
NASDAQ: CLVR · IEX Real-Time Price · USD
1.540
-0.025 (-1.60%)
At close: May 1, 2024, 3:58 PM
1.570
+0.030 (1.95%)
After-hours: May 1, 2024, 6:07 PM EDT
Clever Leaves Holdings Revenue
In the year 2023, Clever Leaves Holdings had annual revenue of $17.42M with 6.14% growth. Revenue in the quarter ending December 31, 2023 was $4.64M with 5.36% year-over-year growth.
Revenue (ttm)
$17.42M
Revenue Growth
+6.14%
P/S Ratio
0.16
Revenue / Employee
$58,841
Employees
296
Market Cap
2.70M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 17.42M | 1.01M | 6.14% |
| Dec 31, 2022 | 16.41M | 1.04M | 6.74% |
| Dec 31, 2021 | 15.37M | 3.26M | 26.88% |
| Dec 31, 2020 | 12.12M | 4.28M | 54.67% |
| Dec 31, 2019 | 7.83M | - | - |
| Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| cbdMD | 23.45M |
| NovaBay Pharmaceuticals | 14.73M |
| iSpecimen | 9.93M |
| INVO Bioscience | 3.02M |
| Tenon Medical | 2.93M |
| Innovative Eyewear | 1.15M |
| 60 Degrees Pharmaceuticals | 253.57K |
CLVR News
- 5 days ago - Clever Leaves Announces Voluntary Delisting and SEC Deregistration - GlobeNewsWire
- 4 weeks ago - Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 2 months ago - High Growth: Top Pot Stocks Making Moves into March 2024 - MarijuanaStocks
- 2 months ago - Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia - GlobeNewsWire
- 4 months ago - Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) - GlobeNewsWire
- 5 months ago - Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors - Business Wire
- 5 months ago - Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder - Business Wire
- 5 months ago - Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses - Business Wire